EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 51 / No 1 (March 2019) J Extra Corpor Technol, 51 1 (2019) 29-37 References
Free Access
Issue
J Extra Corpor Technol
Volume 51, Number 1, March 2019
Page(s) 29 - 37
DOI https://doi.org/10.1051/ject/201951029
Published online 15 March 2019
  1. Kong Y, Chen H, Wang YQ, et al. Direct thrombin inhibitors: Patents 2002–2012. Mol Med Rep. 2014;9:1506–14. [CrossRef] [PubMed] [Google Scholar]
  2. Weitz JI, Hudoba M, Massel D, et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest. 1990;86:385–91. [CrossRef] [PubMed] [Google Scholar]
  3. Di Nisio M, Middeldorp S, Büller HR Direct thrombin inhibitors. N Engl J Med. 2005;353:1028–40. [CrossRef] [PubMed] [Google Scholar]
  4. Nylander S, Mattsson C Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action. Blood Coagul Fibrinolysis. 2003;14:159–67. [CrossRef] [PubMed] [Google Scholar]
  5. Kam P, Kaur N, Thong C Direct thrombin inhibitors: Pharmacology and clinical relevance. Anaesthesia. 2005;60:565–74. [CrossRef] [PubMed] [Google Scholar]
  6. Celikyurt I, Meier CR, Kühne M, et al. Safety and interactions of direct oral anticoagulants with antiarrhythmic drugs. Drug Saf. 2017;40:1091–8. [CrossRef] [PubMed] [Google Scholar]
  7. Härtter S, Sennewald R, Nehmiz G, et al. Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects. Br J Clin Pharmacol. 2013;75:1053–62. [CrossRef] [PubMed] [Google Scholar]
  8. van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate–a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103:1116–27. [CrossRef] [PubMed] [Google Scholar]
  9. Stangier J, Rathgen K, Stähle H, et al. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol. 2007;64:292–303. [CrossRef] [PubMed] [Google Scholar]
  10. Nowak G The ecarin clotting time, a universal method to quantify direct thrombin inhibitors. Pathophysiol Haemost Thromb. 2003;33:173–83. [CrossRef] [PubMed] [Google Scholar]
  11. Siegmund R, Boer K, Poeschel K, et al. Comparison of the ecarin chromogenic assay and different aPTT assays for the measurement of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patients. Thromb Res. 2008;123:159–65. [CrossRef] [PubMed] [Google Scholar]
  12. Duiser HJ, Roelandse FWC, Lentjes EGWM, et al. Iterative model for the calculation of oxyhemoglobin, methemoglobin, and bilirubin in absorbance spectra of cerebrospinal fluid. Clin Chem. 2001;47:338–41. [CrossRef] [PubMed] [Google Scholar]
  13. Mao X, Huang TJ Microfluidic diagnostics for the developing world. Lab Chip. 2012;12:1412–6. [CrossRef] [PubMed] [Google Scholar]
  14. Rumbaut RE, Thiagarajan P Platelet-vessel wall interactions in hemostasis and thrombosis. In: Granger DN, Granger JP, eds. Synthesis Lectures on Integrated Systems Physiology: From Molecules to Function #4. San Rafael, CA: Morgan & Claypool; 2010:29–32. [Google Scholar]
  15. Wu J, Dong M, Santos S, et al. Lab-on-a-chip platforms for detection of cardiovascular disease and cancer biomarkers. Sensors. 2017;17:2934. [CrossRef] [PubMed] [Google Scholar]
  16. Fronczek CF, Park TS, Harshman DK, et al. Paper microfluidic extraction and direct smartphone-based identification of pathogenic nucleic acids from field and clinical samples. RSC Adv. 2014;4:11103–10. [CrossRef] [Google Scholar]
  17. McCracken KE, Tat T, Paz V, et al. Smartphone-based fluorescence detection of bisphenol A from water samples. RSC Adv. 2017;7:9237–43. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.